Differential antagonism of mu agonists by U50,488H in the rat

Frank Porreca, Frank C. Tortella

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Agonist, and antagonist effects of the proposed kappa opioid agonist, U50,488H (U50) have been studied in an experimental model of seizure activity (flurothyl-induced seizure threshold) (ST) and in the central modulation of spontaneous, volume-induced micturition contractions (bladder motility) (BM) in rats. Intracerebroventricular (i.c.v.) administration of U50 (at the doses tested) did not produce any agonist effect in either ST or in BM. In contrast, i.c.v. administration of [D-Ala2, NMPhe4, Gly-o1]enkephalin (DAGO) or etorphine, agonists with activity at mu opioid receptors, produced an elevation of ST and inhibition of BM. The elevation in ST produced by etorphine (0.004 nmol) was prevented by prior treatment with U50. In contrast, the approximately equieffective elevation in ST resulting from DAGO was not affected by U50 pretreatment. Similarly, pretreatment of rats with U50 antagonized the approximately equieffective BM effects of etorphine, but not those of DAGO. As both DAGO and etorphine are thought to exert their effects via the opiate mu receptor, the results may be consistent with the view that subpopulations of mu receptors exist within the central nervous system; these sites may be differentially associated with the kappa receptor.

Original languageEnglish (US)
Pages (from-to)2511-2516
Number of pages6
JournalLife Sciences
Volume41
Issue number23
DOIs
StatePublished - Dec 7 1987

Fingerprint

Etorphine
Enkephalins
Rats
mu Opioid Receptor
Urinary Bladder
Opiate Alkaloids
Seizures
Flurothyl
kappa Opioid Receptor
Urination
Neurology
Opioid Receptors
Opioid Analgesics
Theoretical Models
Central Nervous System
Modulation

ASJC Scopus subject areas

  • Pharmacology

Cite this

Differential antagonism of mu agonists by U50,488H in the rat. / Porreca, Frank; Tortella, Frank C.

In: Life Sciences, Vol. 41, No. 23, 07.12.1987, p. 2511-2516.

Research output: Contribution to journalArticle

Porreca, Frank ; Tortella, Frank C. / Differential antagonism of mu agonists by U50,488H in the rat. In: Life Sciences. 1987 ; Vol. 41, No. 23. pp. 2511-2516.
@article{dc30ee1360544541abce7bd089c4904e,
title = "Differential antagonism of mu agonists by U50,488H in the rat",
abstract = "Agonist, and antagonist effects of the proposed kappa opioid agonist, U50,488H (U50) have been studied in an experimental model of seizure activity (flurothyl-induced seizure threshold) (ST) and in the central modulation of spontaneous, volume-induced micturition contractions (bladder motility) (BM) in rats. Intracerebroventricular (i.c.v.) administration of U50 (at the doses tested) did not produce any agonist effect in either ST or in BM. In contrast, i.c.v. administration of [D-Ala2, NMPhe4, Gly-o1]enkephalin (DAGO) or etorphine, agonists with activity at mu opioid receptors, produced an elevation of ST and inhibition of BM. The elevation in ST produced by etorphine (0.004 nmol) was prevented by prior treatment with U50. In contrast, the approximately equieffective elevation in ST resulting from DAGO was not affected by U50 pretreatment. Similarly, pretreatment of rats with U50 antagonized the approximately equieffective BM effects of etorphine, but not those of DAGO. As both DAGO and etorphine are thought to exert their effects via the opiate mu receptor, the results may be consistent with the view that subpopulations of mu receptors exist within the central nervous system; these sites may be differentially associated with the kappa receptor.",
author = "Frank Porreca and Tortella, {Frank C.}",
year = "1987",
month = "12",
day = "7",
doi = "10.1016/0024-3205(87)90435-8",
language = "English (US)",
volume = "41",
pages = "2511--2516",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "23",

}

TY - JOUR

T1 - Differential antagonism of mu agonists by U50,488H in the rat

AU - Porreca, Frank

AU - Tortella, Frank C.

PY - 1987/12/7

Y1 - 1987/12/7

N2 - Agonist, and antagonist effects of the proposed kappa opioid agonist, U50,488H (U50) have been studied in an experimental model of seizure activity (flurothyl-induced seizure threshold) (ST) and in the central modulation of spontaneous, volume-induced micturition contractions (bladder motility) (BM) in rats. Intracerebroventricular (i.c.v.) administration of U50 (at the doses tested) did not produce any agonist effect in either ST or in BM. In contrast, i.c.v. administration of [D-Ala2, NMPhe4, Gly-o1]enkephalin (DAGO) or etorphine, agonists with activity at mu opioid receptors, produced an elevation of ST and inhibition of BM. The elevation in ST produced by etorphine (0.004 nmol) was prevented by prior treatment with U50. In contrast, the approximately equieffective elevation in ST resulting from DAGO was not affected by U50 pretreatment. Similarly, pretreatment of rats with U50 antagonized the approximately equieffective BM effects of etorphine, but not those of DAGO. As both DAGO and etorphine are thought to exert their effects via the opiate mu receptor, the results may be consistent with the view that subpopulations of mu receptors exist within the central nervous system; these sites may be differentially associated with the kappa receptor.

AB - Agonist, and antagonist effects of the proposed kappa opioid agonist, U50,488H (U50) have been studied in an experimental model of seizure activity (flurothyl-induced seizure threshold) (ST) and in the central modulation of spontaneous, volume-induced micturition contractions (bladder motility) (BM) in rats. Intracerebroventricular (i.c.v.) administration of U50 (at the doses tested) did not produce any agonist effect in either ST or in BM. In contrast, i.c.v. administration of [D-Ala2, NMPhe4, Gly-o1]enkephalin (DAGO) or etorphine, agonists with activity at mu opioid receptors, produced an elevation of ST and inhibition of BM. The elevation in ST produced by etorphine (0.004 nmol) was prevented by prior treatment with U50. In contrast, the approximately equieffective elevation in ST resulting from DAGO was not affected by U50 pretreatment. Similarly, pretreatment of rats with U50 antagonized the approximately equieffective BM effects of etorphine, but not those of DAGO. As both DAGO and etorphine are thought to exert their effects via the opiate mu receptor, the results may be consistent with the view that subpopulations of mu receptors exist within the central nervous system; these sites may be differentially associated with the kappa receptor.

UR - http://www.scopus.com/inward/record.url?scp=0023622773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023622773&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(87)90435-8

DO - 10.1016/0024-3205(87)90435-8

M3 - Article

C2 - 2824958

AN - SCOPUS:0023622773

VL - 41

SP - 2511

EP - 2516

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 23

ER -